Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Katsiaryna Bykov"'
Autor:
Shahar, Shmuel, Charles E, Leonard, Katsiaryna, Bykov, Kristian B, Filion, Marissa J, Seamans, Jennifer L, Lund
Publikováno v:
American Journal of Epidemiology. 192:323-327
Epidemiological training often requires specialization in a subdiscipline (e.g., pharmacoepidemiology, genetic epidemiology, social epidemiology, or infectious disease epidemiology). While specialization is necessary and beneficial, it comes at the c
Autor:
Nazleen F. Khan, Katsiaryna Bykov, Michael L. Barnett, Robert J. Glynn, Seanna M. Vine, Joshua J. Gagne
Publikováno v:
Neurology. 99:e1432-e1442
Background and ObjectivesThe concomitant use of prescription opioids and skeletal muscle relaxants has been associated with opioid overdose, but little data exist on the head-to-head safety of these drug combinations. The objective of this study was
Autor:
Elvira D’Andrea, Hemin Lee, Mengdong He, Elisabetta Patorno, Jessica M. Franklin, Katsiaryna Bykov, Jennifer S. Graff
Publikováno v:
Clin Pharmacol Ther
Many real-word evidence (RWE) studies that utilize existing healthcare data to evaluate treatment effects incur substantial but avoidable bias from methodologically flawed study design; however, the extent of preventable methodological pitfalls in cu
Publikováno v:
Clinical Pharmacology & Therapeutics. 110:1011-1017
Polypharmacy is common among patients taking prescription opioids long-term, and the codispensing of interacting medications may further increase opioid overdose risk. To identify nonopioid medications that may increase opioid overdose risk in this p
Autor:
Aaron S. Kesselheim, Mayookha Mitra-Majumdar, Gerald J. Dal Pan, Joshua J. Gagne, Ellen Pinnow, Krista F. Huybrechts, Ameet Sarpatwari, Esther H. Zhou, Steven Woloshin, Gita A. Toyserkani, Claudia Manzo, Jerry Avorn, Kristyn Chin, Katsiaryna Bykov, Cynthia LaCivita, William Feldman
Publikováno v:
Drug Safety. 44:743-751
Since 2007, the US Food and Drug Administration has had the authority to require risk evaluation and mitigation strategy (REMS) programs for certain medications with serious safety concerns to help ensure the benefits of the medication outweigh its r
Autor:
Kueiyu Joshua Lin, Daniel E. Singer, Katsiaryna Bykov, Lily G. Bessette, Julianna M. Mastrorilli, Alexander Cervone, Dae Hyun Kim
Publikováno v:
JAMA Network Open. 6:e234086
ImportanceThe development of an optimal stroke prevention strategy, including the use of oral anticoagulant (OAC) therapy, is particularly important for patients with atrial fibrillation (AF) who are living with dementia, a condition that increases t
Trends in the Use of Oral Anticoagulants for Adults With Venous Thromboembolism in the US, 2010-2020
Publikováno v:
JAMA Network Open. 6:e234059
ImportanceThe introduction of direct oral anticoagulants (DOACs) has transformed the treatment of venous thromboembolism (VTE). Large health care databases offer valuable insight into how oral anticoagulants (OACs) are used in clinical practice and m
Autor:
Junyi Wang, Joshua J Gagne, Sushama Kattinakere-Sreedhara, Michael A Fischer, Katsiaryna Bykov
Publikováno v:
BMJ. :e069931
Objective To evaluate the association between initiation of fluoroquinolones and hospital admission or emergency department visit for suicidality. Design Population based cohort study. Setting IBM MarketScan database, USA. Participants 2 756 268 adul
Autor:
Elisabetta Patorno, Jessica M. Franklin, Katsiaryna Bykov, Mengdong He, Elizabeth M. Garry, John D. Seeger
Publikováno v:
Diabetes, Obesity and Metabolism. 21:2029-2038
AIM: Recent years have witnessed a proliferation of observational research examining the association between glucose-lowering medications and cancer, paired with an increasing concern on the quality of the produced evidence. Our objective was to revi